Postes actifs de Sylvain Monnier-Benoit
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Novigenix SA
 Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | Fondateur | 01/01/2014 | - |
| Corporate Officer/Principal | 01/01/2014 | - |
Historique de carrière de Sylvain Monnier-Benoit
Anciens postes connus de Sylvain Monnier-Benoit
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Diagnoplex SA
 Diagnoplex SA Medical SpecialtiesHealth Technology Diagnoplex SA develops molecular diagnostics for colon cancer. It lead product, Colox is a minimally-invasive blood test developed for the systematic screening and detection of early and advanced colorectal cancer. The company was founded in April 2005 by Stavros Therianos, Curzio Roberto Maria Rüegg, Jacques R. Essinger and Jean-Pierre Rosat and is headquartered in Lausanne, Switzerland. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Suisse | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Diagnoplex SA
Diagnoplex SA Medical SpecialtiesHealth Technology Diagnoplex SA develops molecular diagnostics for colon cancer. It lead product, Colox is a minimally-invasive blood test developed for the systematic screening and detection of early and advanced colorectal cancer. The company was founded in April 2005 by Stavros Therianos, Curzio Roberto Maria Rüegg, Jacques R. Essinger and Jean-Pierre Rosat and is headquartered in Lausanne, Switzerland. | Health Technology |
Novigenix SA
Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | Health Technology |
- Bourse
- Insiders
- Sylvain Monnier-Benoit
- Expérience
